Infant children’s nonprescription cough and cold medicines recall Johnson & Johnson Wyeth McNeil
October 11, 2007 by Jay Genkins
Filed under Defective Products, FDA
Fort Washington, PA (October 11, 2007)
McNeil Consumer Healthcare, a division of McNeil-PPC, Inc., announced today that the company is voluntarily withdrawing certain infants’ cough and cold products from the market. When used as directed, these medicines are generally recognized as safe and effective. While most parents use these medicines appropriately and follow dosing directions, an assessment of available data on the use of pediatric cough and cold medicines has identified rare instances of misuse leading to overdose, particularly in infants under two years of age.
For more information and a list of brands that are part of the recall visit the children’s cough and cold medicine recall page.
MSNBC News Coverage of the Story. Video Opens in a New Window
Also, the Consumer Healthcare Products Association (CHPA), on behalf of the leading makers of over-the-counter (OTC) cough and cold medicines, announced the voluntary withdrawal of oral infant medications from store shelves.
Some of the Products being Recalled.
Other Resources:
www.otcsafety.org/
